Abdullah Ozkaya
Overview
Explore the profile of Abdullah Ozkaya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
426
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cakmak S, Demir G, Tunc U, Sukun E, Akbas Y, Ozkaya A, et al.
Arq Bras Oftalmol
. 2024 Sep;
88(2):e20230229.
PMID: 39319910
Purpose: To compare the outcomes of intravitreal dexamethasone implant used as either an adjuvant or a switching therapy for diabetic macular edema in patients with poor anatomic response after three...
2.
Bozkurt E, Kaplan F, Onder Tokuc E, Aykut A, Ozsoy Saygin I, Kanar H, et al.
Int Ophthalmol
. 2024 Sep;
44(1):391.
PMID: 39317810
Purpose: The aim of this study is to investigate the effect of vitreomacular interface disorders (VMID) on treatment response in patients treated with anti-vascular endothelial growth factor (anti-VEGF) due to...
3.
Onder Tokuc E, Karabas V, Sevik M, Kaplan F, Kutluturk Karagoz I, Kanar H, et al.
Eur J Ophthalmol
. 2024 Sep;
:11206721241280737.
PMID: 39234628
Purpose: This study aimed to compare the effect of intravitreal aflibercept (IVA) and ranibizumab (IVR) on the maximal diameter of the largest intraretinal cyst (mdIRC), indicating chronicity in patients with...
4.
Limon D, Kaplan F, Saygin I, Onder Tokuc E, Kutluturk Karagoz I, Kanar H, et al.
Semin Ophthalmol
. 2024 Aug;
39(6):460-467.
PMID: 39087722
Purpose: To evaluate the responses of different optical coherence tomography (OCT) patterns of diabetic macular edema (DME) to intravitreal injection therapy. Methods: In this retrospective, comparative, and multicenter study, patients...
5.
Yayla U, Sevik M, Karabas V, Sahin O, Ozkaya A, Yenerel N, et al.
Turk J Ophthalmol
. 2023 Dec;
53(6):356-368.
PMID: 38126607
Objectives: This study aimed to report the demographic and clinical characteristics of diabetic macular edema (DME) patients treated with intravitreal injection (IVI) of anti-vascular endothelial growth factors (anti-VEGF) and provide...
6.
Kaldirim H, Ozkaya A, Karabas L, Alagoz C, Alkin Z, Altunay O, et al.
Beyoglu Eye J
. 2023 Jul;
8(2):73-80.
PMID: 37521880
Objectives: The aim of the study was comparison of wet-type age-related macular degeneration in phakic and pseudophakic patients in terms of anatomical and functional success based on the real-life data...
7.
Erdogan G, Gumus G, Gunay B, Ozkaya A
Indian J Ophthalmol
. 2023 Jun;
71(6):2622.
PMID: 37322714
No abstract available.
8.
Ozturk M, Ozkaya A, Karabas L, Alagoz C, Alkin Z, Artunay O, et al.
Photodiagnosis Photodyn Ther
. 2023 Jun;
42:103640.
PMID: 37263398
Background: To investigate the anatomical and visual outcomes of the patients with neovascular age-related macular degeneration (nAMD) treated with anti-vascular endothelial growth factor (anti-VEGF), according to the baseline best-corrected visual...
9.
Erdogan G, Gumus G, Gunay B, Ozkaya A
Indian J Ophthalmol
. 2023 Jan;
71(1):174-179.
PMID: 36588230
Purpose: To evaluate the efficacy and safety of posterior sub-Tenon triamcinolone (PSTA) in chronic postoperative cystoid macular edema (PCME) after pars plana vitrectomy (PPV). Methods: Consecutive 22 patients who developed...
10.
Eris E, Perente I, Erdogan G, Seymen Z, Sucu M, Ozkaya A, et al.
Beyoglu Eye J
. 2022 Feb;
4(1):11-16.
PMID: 35187425
Objectives: Branch retinal vein occlusion (BRVO) is the second most common type of retinal vascular disorder. Both inflammation and increased vascular endothelial growth factor (VEGF) levels play important roles in...